Flumazenil for Benzodiazepine Reversal in Electroconvulsive Therapy

Clinical trial NCT07619092 · RECRUITING

Trial details

NCT number: NCT07619092
Sponsor: Anders Jørgensen
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Depression - Major Depressive Disorder Bipolar Disorder (BD)Functional Magnetic Resonance Imaging (fMRI)Cognition Autobiographical Memory Electroconvulsive Therapy ECT Treatment Outcome Inpatients

Start date: 2026-01-15
Primary completion: 2028-08-01
Enrollment: 145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.